Next Article in Journal
Antibacterial Activity of Shikimic Acid from Pine Needles of Cedrus deodara against Staphylococcus aureus through Damage to Cell Membrane
Next Article in Special Issue
Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry
Previous Article in Journal
EZH2 in Bladder Cancer, a Promising Therapeutic Target
Previous Article in Special Issue
Determination of Oxidized Phosphatidylcholines by Hydrophilic Interaction Liquid Chromatography Coupled to Fourier Transform Mass Spectrometry
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(11), 27133-27144;

Developments in FTICR-MS and Its Potential for Body Fluid Signatures

Center for Proteomics and Metabolomics, Leiden University Medical Center (LUMC), PO Box 9600, 2300 RC Leiden, The Netherlands
PerkinElmer, San Jose Technology Center, San Jose, CA 95134, USA
Author to whom correspondence should be addressed.
Academic Editor: Laszlo Prokai
Received: 22 September 2015 / Revised: 3 November 2015 / Accepted: 5 November 2015 / Published: 13 November 2015
(This article belongs to the Special Issue Fourier Transform Mass Spectrometry in Molecular Sciences)
Full-Text   |   PDF [1077 KB, uploaded 17 November 2015]   |  


Fourier transform mass spectrometry (FTMS) is the method of choice for measurements that require ultra-high resolution. The establishment of Fourier transform ion cyclotron resonance (FTICR) MS, the availability of biomolecular ionization techniques and the introduction of the Orbitrap™ mass spectrometer have widened the number of FTMS-applications enormously. One recent example involves clinical proteomics using FTICR-MS to discover and validate protein biomarker signatures in body fluids such as serum or plasma. These biological samples are highly complex in terms of the type and number of components, their concentration range, and the structural identity of each species, and thus require extensive sample cleanup and chromatographic separation procedures. Clearly, such an elaborate and multi-step sample preparation process hampers high-throughput analysis of large clinical cohorts. A final MS read-out at ultra-high resolution enables the analysis of a more complex sample and can thus simplify upfront fractionations. To this end, FTICR-MS offers superior ultra-high resolving power with accurate and precise mass-to-charge ratio (m/z) measurement of a high number of peptides and small proteins (up to 20 kDa) at isotopic resolution over a wide mass range, and furthermore includes a wide variety of fragmentation strategies to characterize protein sequence and structure, including post-translational modifications (PTMs). In our laboratory, we have successfully applied FTICR “next-generation” peptide profiles with the purpose of cancer disease classifications. Here we will review a number of developments and innovations in FTICR-MS that have resulted in robust and routine procedures aiming for ultra-high resolution signatures of clinical samples, exemplified with state-of-the-art examples for serum and saliva. View Full-Text
Keywords: mass spectrometry; proteomics; solid-phase extraction; ultra-high resolving power; FTICR-MS; instrumental development; serum; saliva; clinical cohort; profiling mass spectrometry; proteomics; solid-phase extraction; ultra-high resolving power; FTICR-MS; instrumental development; serum; saliva; clinical cohort; profiling

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Nicolardi, S.; Bogdanov, B.; Deelder, A.M.; Palmblad, M.; van der Burgt, Y.E.M. Developments in FTICR-MS and Its Potential for Body Fluid Signatures. Int. J. Mol. Sci. 2015, 16, 27133-27144.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top